A non-convulsant delta-opioid receptor agonist, KNT-127, reduces cortical spreading depression and nitroglycerin-induced allodynia.
Zachariah BertelsWiktor D WitkowskiSarah AsifKendra SiegersmaRichard M Van RijnAmynah Amir Ali PradhanPublished in: Headache (2020)
This study shows that the antimigraine effects of DOR agonists can be separated from their proconvulsant effects. This data provides valuable information for the continued development of delta agonists for the treatment of migraine.